Articles From: The Medicines Company Reports Second Quarter and First Half 2014 Results to MAXIMUS Schedules Fiscal 2014 Third Quarter Conference Call


The Medicines Company (NASDAQ:MDCO), a global company focused on saving lives, alleviating suffering, and contributing to the economics of healthcare by focusing on the world's leading acute/intensive care hospitals, today announced second quarter and first half results for 2014.
Sign-up for The Medicines Company Reports Second Quarter and First Half 2014 Results investment picks
NEW YORK , July 23, 2014 /PRNewswire/ -- OTC Markets Group Inc. (OTCQX: OTCM), operator of Open, Transparent and Connected financial marketplaces, today announced that Mission Valley Bancorp (OTCQX: MVLY), the holding company of Mission Valley Bank in Sun Valley, CA , has qualified to trade on OTCQX®, the best marketplace.
Sign-up for OTC Markets Group Welcomes Mission Valley Bancorp to OTCQX® investment picks
WAKEFIELD, Mass., July 23, 2014 (GLOBE NEWSWIRE) -- Comverse (Nasdaq:CNSI) , a global leader in digital services and monetization solutions, announced the inauguration of its new state-of-the-art Comverse Center of Excellence (CCoE) in Gurgaon, India.
Sign-up for Comverse Inaugurates New APAC Center of Excellence in India investment picks
CHICAGO, July 23, 2014 (GLOBE NEWSWIRE) -- Merge Healthcare Incorporated (Nasdaq:MRGE) , a leading provider of innovative enterprise imaging, interoperability and clinical systems that seek to advance healthcare, announced today the scheduling of its second quarter 2014 earnings call, which will be held at 8:30 AM ET on Wednesday, July 30, 2014.
Sign-up for Merge Sets Second Quarter 2014 Earnings Call investment picks
CC Media Holdings, Inc. (OTCBB:CCMO) today reported financial results for the second quarter ended June 30, 2014.
Sign-up for CC Media Holdings, Inc. Reports Results for 2014 Second Quarter investment picks
Clear Channel Outdoor Holdings, Inc. (NYSE:CCO) today reported financial results for the second quarter ended June 30, 2014.
Sign-up for Clear Channel Outdoor Holdings, Inc. Reports Results for 2014 Second Quarter investment picks
Expanded range of BGC Partners over-the-counter data available via Eikon and Elektron with new market data distribution & access model NEW YORK , July 23, 2014 /PRNewswire/ -- Thomson Reuters, the world's leading source of intelligent information for businesses and professionals, and BGC Partners, Inc. (NASDAQ: BGCP) ("BGC Partners" or "BGC"), a leading global brokerage company servicing the financial and real estate markets, today announced a strategic agreement to expand customer access to over-the-counter (OTC) pricing data.
Sign-up for Thomson Reuters Increases OTC Data Coverage through Expanded Partnership with BGC Partners investment picks
Garmin International Inc., a unit of Garmin Ltd.
Sign-up for Garmin® Team X Introduces New G3X™ Touch 7-Inch Touchscreen Display Option and Connext™ Cockpit Connectivity for Experimental Aircraft investment picks
HOUSTON , July 23, 2014 /PRNewswire/ -- Hercules Offshore, Inc. (Nasdaq: HERO) today reported income from continuing operations of $6.6 million , or $0.04 per diluted share, on revenue of $243.0 million for the second quarter 2014, compared to income from continuing operations of $16.6 million , or $0.10 per diluted share, on revenue of $211.5 million for the second quarter 2013.
Sign-up for Hercules Offshore Announces Second Quarter 2014 Results investment picks
Solution to facilitate time of day and zero-rated app-centric plans for 4 Million Subscribers HOD HASHARON, Israel , July 23, 2014 /PRNewswire/ -- Allot Communications Ltd .
Sign-up for Allot Communications Receives Order from Tier-1 Mobile Operator in EMEA for Analytics and App-Centric Plans investment picks
The Interactive Media Council, Inc. (IMC) has selected Delaware’s Hunter Trapper Registration Web application as the recipient of its Outstanding Achievement Award.
Sign-up for Delaware Hunter Trapper Registration System Wins National Award investment picks
Eagle Pharmaceuticals, Inc. (“Eagle” or “the Company”) (Nasdaq:EGRX) today announced that the U.
Sign-up for FDA Approves Eagle Pharmaceuticals’ Ryanodex® for the Treatment of Malignant Hyperthermia investment picks
District Court Judge Orders Apotex to Immediately Recall the Authorized Generic from its Direct Customers and to Stop Selling and Supplying the Product PITTSBURGH , July 23, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that the U.S. District Court for the District of New Jersey granted its motion for a temporary restraining order against Apotex Inc. and Apotex Corporation in litigation relating to Paroxetine CR, the authorized generic of GlaxoSmithKline's Paxil ® CR.
Sign-up for Mylan Wins Motion for Temporary Restraining Order Against Apotex for Authorized Generic of Paxil® CR investment picks
Enphase Energy, Inc. (NASDAQ: ENPH) announced today that Australian Sustainable Energy Services (ASES) has installed an Enphase ® System at Hartley’s Crocodile Adventures , an eco-adventure attraction featuring Australia’s enchanting wildlife.
Sign-up for Enphase Energy Helps Hartley’s Crocodile Adventures Take A Bite Out of Electrical Bill investment picks
Joseph Corasanti Steps Down as CEO UTICA, N.Y., July 23, 2014 (GLOBE NEWSWIRE) -- CONMED Corporation (Nasdaq:CNMD) today announced that Joseph Corasanti is stepping down as Chief Executive Officer, President and a member of the Board of Directors, effective immediately.
Sign-up for CONMED Corporation Announces Leadership Transition investment picks
WAKE FOREST, N.C. , July 23, 2014 /PRNewswire/ -- PowerSecure International, Inc. (NYSE: POWR) today announced it has been awarded approximately $140 million of new distributed generation (DG) business.
Sign-up for PowerSecure Adds $140 Million In New Distributed Generation Business investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0958808001&sourceType=1 http://media3.marketwire.com/logos/20140303-GXIlogoLG.png TORONTO, ONTARIO --
Sign-up for GuestLogix to Announce Fiscal 2014 Second Quarter Results on August 11, 2014 investment picks
Strengthens Leadership Position in Treatments for Hunter syndrome and Commitment to MPS II Patient Community LEXINGTON, Massachusetts , July 23, 2014 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPG), the global specialty biopharmaceutical company, and ArmaGen, a US privately held biotechnology company, today announced a worldwide licensing and collaboration agreement for AGT-182, an investigational enzyme replacement therapy (ERT) for the potential treatment of both the central nervous system (CNS) and somatic manifestations in patients with Hunter syndrome (MPS II). This collaboration strengthens Shire's rare disease pipeline of innovative therapies where there is high unmet need, and underscores the company's long standing commitment to the Hunter syndrome community.
Sign-up for Shire Enters Strategic Licensing and Collaboration Agreement With ArmaGen investment picks
Acquisition Strengthens Company's Focus on Communications Infrastructure ALISO VIEJO, Calif.
Sign-up for Microsemi Acquires Mingoa investment picks
New York Community Bancorp, Inc. (NYSE:NYCB) (the “Company”) today reported GAAP earnings of $118.7 million, or $0.27 per diluted share, for the three months ended June 30, 2014 and $233.9 million, or $0.53 per diluted share, for the six months ended at that date.
Sign-up for New York Community Bancorp, Inc. Reports 2Q 2014 Diluted Non-GAAP Cash Earnings Per Share of $0.29 (1) and Diluted GAAP Earnings Per Share of $0.27 investment picks
BOSTON, July 23, 2014 (GLOBE NEWSWIRE) -- NewStar Financial, Inc. (Nasdaq:NEWS) announced today that it will report results for the second quarter of 2014 on Wednesday, August 6, 2014 before the markets open.
Sign-up for NewStar Financial Schedules Release of Results for the Second Quarter of 2014 investment picks
The Dow Chemical Company (NYSE: DOW): Second Quarter 2014 Highlights The Company reported earnings of $0.73 per share, or $0.74 per share on an adjusted basis (1) .
Sign-up for Dow Reports Second Quarter Results investment picks
BETHESDA, Maryland and ABINGDON, Oxfordshire, July 23, 2014 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP) , a global biopharmaceutical company, today announced that the United Kingdom's National Institute of Health and Care Excellence (NICE) has published the technology appraisal guidance recommending the use of AMITIZA ® (lubiprostone) in the treatment of chronic idiopathic constipation (CIC) and associated symptoms in adults who have failed laxatives.
Sign-up for Sucampo Announces Publication of NICE Recommendation for AMITIZA(R) (Lubiprostone) investment picks
Biogen Idec Inc. (NASDAQ: BIIB) today reported second quarter 2014 results, including revenue of $2.4 billion, a 40% increase compared to the second quarter of 2013.
Sign-up for Biogen Idec Second Quarter 2014 Revenues Increase 40% to $2.4 Billion; Company Raises Financial Guidance for the Year investment picks
Piling Contractors Can Now Realize Increased Productivity with Trimble 3D Machine Control SUNNYVALE, Calif.
Sign-up for Trimble Announces Land-based 3D Piling Application for Mixed Fleets investment picks
SITECH Intermountain Joins the First Fully Dedicated Global Distribution Network for Construction Technology Solutions SUNNYVALE, Calif.
Sign-up for SITECH Technology Dealer Established in the Intermountain Region to Serve Heavy Civil Construction Contractors investment picks
Integrated Device Technology, Inc. ( IDT ® ) (NASDAQ:IDTI) today announced the expansion of its leading PCIe timing portfolio with the industry’s first 1.5 V PCI Express (PCIe ® ) buffer family .
Sign-up for IDT Announces 1.5 Volt PCI Express® Clock Buffer Family Offering Industry-leading Space and Power Savings investment picks
SPOKANE, Wash., July 23, 2014 (GLOBE NEWSWIRE) -- Potlatch Corporation (Nasdaq:PCH) today reported net income of $16.3 million, or $0.40 per diluted share, on revenues of $143.9 million for the quarter ended June 30, 2014.
Sign-up for Potlatch Reports Second Quarter 2014 Results investment picks
SAGE Therapeutics, a biopharmaceutical company developing novel medicines to treat life-threatening, rare central nervous system (CNS) disorders, today announced the closing of its initial public offering of 5,750,000 shares of its common stock at a public offering price of $18.00 per share, before underwriting discounts, which includes the exercise in full by the underwriters of their option to purchase up to 750,000 additional shares of common stock.
Sign-up for SAGE Therapeutics Announces Closing of Initial Public Offering investment picks
MAXIMUS (NYSE: MMS), a leading provider of government services worldwide, will issue a press release with its financial results for the three and nine months ended June 30, 2014, at 6:30 a.m. (ET) on Thursday, August 7, 2014, and will host a conference call the same day at 9:00 a.m. (ET). The call can be accessed under the Investor Relations page ( http://investor.maximus.com ) of the Company’s website or by calling: 877.407.8289 (Domestic)/201.689.8341 (International) For those unable to listen to the live call, a replay will be available through August 21, 2014.
Sign-up for MAXIMUS Schedules Fiscal 2014 Third Quarter Conference Call investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: The Medicines Company Reports Second Quarter and First Half 2014 Results to MAXIMUS Schedules Fiscal 2014 Third Quarter Conference Call
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices